Kolexia
Berger Claire Pédiatrie
Berger Claire
Pédiatrie
Hôpital Nord CHU Saint-Étienne - Loire
Saint-Priest-en-Jarez, France
178 Activités
259 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Hémophilie A Seconde tumeur primitive Leucémies Médulloblastome Anémie Tumeurs du cerveau Gliome COVID-19 Tumeurs neuroectodermiques primitives

Collaborateurs

Voir plus
Conter Cecile
Conter Cecile
Centre Léon-Bérard, Lyon, France
Thouvenin-Doulet Sandrine
Thouvenin-Doulet Sandrine
Hôpital Nord CHU Saint-Étienne - Loire, Saint-Priest-en-Jarez, France
Harroche-Angel Annie
Harroche-Angel Annie
Hôpital Necker Enfants Malades, Paris, France
Trombert-Paviot Béatrice
Trombert-Paviot Béatrice
CHU Saint-Étienne, Saint-Étienne, France

Industries

Voir plus
Sobi
8 collaboration(s)
Dernière en 2023
Octapharma
4 collaboration(s)
Dernière en 2022
Takeda Pharmaceutical
2 collaboration(s)
Dernière en 2021
Sanofi
1 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
BIOMEDE 2: Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication
Essai Clinique (Chimerix)   29 février 2024
A Study of BAX 930 in Children, Teenagers, and Adults Born With Thrombotic Thrombocytopenic Purpura (TTP): A Phase 3, Prospective, Randomized, Controlled, Open-label, Multicenter, 2 Period Crossover Study With a Single Arm Continuation Evaluating the Safety And Efficacy of BAX 930 (rADAMTS13) in the Prophylactic And On-demand Treatment of Subjects With Severe Congenital Thrombotic Thrombocytopenic Purpura (cTTP, Upshaw-Schulman Syndrome [USS], Hereditary Thrombotic Thrombocytopenic Purpura [hTTP])
Essai Clinique (Shire)   26 février 2024
START_MOOC2: Personalized Massive Online Open Course After Childhood Cancer: Impact Study START-MOOC2
Essai Clinique (CHU Saint-Étienne)   16 février 2024
MICCHADO: Molecular and Immunological Characterisation of High Risk CHildhood Cancer At DiagnOsis, Treatment and Follow-up - Biological Evaluation in Children, Adolescents and Young Adults -
Essai Clinique (Institut Curie)   02 février 2024
Association of European Paediatric and Congenital Cardiology practical recommendations for surveillance and prevention of cardiac disease in childhood cancer survivors: the importance of physical activity and lifestyle changes From the Association of European Paediatric and Congenital Cardiology Working Group Sports Cardiology, Physical Activity and Prevention, Working Group Adult Congenital Heart Disease, Working Group Imaging and Working Group Heart Failure.
Cardiology in the young   04 janvier 2024
ctDNA quantification improves estimation of outcomes in patients with high grade osteosarcoma: a translational study from the OS2006 trial.
Annals of oncology : official journal of the European Society for Medical Oncology   22 décembre 2023
A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura: A Phase 3b, Prospective, Open-label, Multicenter, Single Treatment Arm, Continuation Study of the Safety and Efficacy of TAK-755 (rADAMTS13, Also Known as BAX 930/SHP655) in the Prophylactic and On-demand Treatment of Subjects With Severe Congenital Thrombotic Thrombocytopenic Purpura (cTTP; Upshaw-Schulman Syndrome, or Hereditary Thrombotic Thrombocytopenic Purpura)
Essai Clinique (Takeda Pharmaceutical)   02 novembre 2023
NATIONAL BREAST AND THYROID SCREENING AFTER A TREATMENT RECEIVED AGAINST A CANCER DURING CHILDHOOD A DENACAPST FRENCH COHORT
Abstracts from the 55th Congress of the International Society of Paediatric Oncology (SIOP) October 11–14, 2023   02 novembre 2023
INTER-INDIVIDUAL VARIATION IN GONADOTOXICITY IN FEMALE CHILDHOOD CANCER SURVIVORS – A GENOME-WIDE ASSOCIATION STUDY: RESULTS FROM THE PANCARELIFE STUDY
Abstracts from the 55th Congress of the International Society of Paediatric Oncology (SIOP) October 11–14, 2023   02 novembre 2023
Protect-NOW: Practical Utilisation of Octapharma FVIII Concentrates in Previously Untreated & Minimally Treated Haemophilia A Patients Entering Routine Clinical Treatment With Nuwiq, Octanate or Wilate - Efficacy & Safety Observational Study-Protect-NOW
Essai Clinique (Octapharma)   01 novembre 2023